Clinical trials: Post Herpetic Neuralgia
Herpes Zoster
Efficacy of Pregabalin for the Treatment of Acute Herpetic Neuralgia
All eligible Herpes Zoster patients will be randomized into two groups. Group 1 will be the treatment group receiving Pregabalin 75 mg twice daily for 4 weeks in addition to other routine treatment.
- Trial name
- NCT03809702
- Testing
- Pregabalin
- Where
- Nepal
- Volunteers
- 82 people
- Sponsor
- B.P. Koirala Institute of Health Sciences
Post Herpetic Neuralgia
A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia
This study was performed to evaluate the local and systemic safety profile and the analgesic efficacy of long-term treatment with lidocaine 5% medicated plaster (Lido-Patch).
- Trial name
- NCT03765697
- Testing
- Lidocaine 5% medicated plaster
- Volunteers
- 259 people
- Sponsor
- Grünenthal GmbH
Postherpetic Neuralgia
A Study to Determine if an Investigational Pain Medicine Provides Relief of Chronic Pain After a Shingles Outbreak
The purpose of this study is to determine whether T-62 is effective in providing relief of pain that can occur after an individual experiences a shingles outbreak, which is an infection in adults caused by the same virus that…
- Trial name
- NCT00506610
- Testing
- T-62
- Where
- 8 sites in United States
- Sponsor
- Pfizer
Pain
Prevention of Post Herpetic Neuralgia by Ultrasound Guided Single Nerve Block in the ED
Herpes zoster causes significant morbidity on over 1 million Americans every year. Although the majority of herpes zoster pain will self-resolve within one week, a significant proportion of patients will develop postherpetic…
- Trial name
- NCT04530162
- Testing
- Ultrasound guided nerve block
- Where
- United States
- Sponsor
- Antonios Likourezos
Postherpetic Neuralgia
Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia
This study will compare Z160 and placebo in patients with Postherpetic Neuralgia for safety and efficacy for a period of 6 weeks.
- Trial name
- PHN (NCT01757873)
- Testing
- Z160
- Where
- 53 sites in United States
- Volunteers
- 144 people
- Sponsor
- Zalicus
PHN - Post-Herpetic Neuritis
Platelet-rich Plasma in the Treatment of Intractable Postherpetic Neuralgia
used ultrasound-guided platelet rich plasma nerve block to treat Intractable Postherpetic Neuralgia.
- Trial name
- NCT05444413
- Testing
- ultrasound-guided platelet rich plasma nerve block
- Where
- China
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- Affiliated Hospital of Nantong University
Herpes Zoster
Clinical and Economic Impact of Herpes Zoster in Cancer Patients
Herpes zoster (HZ) is an important infectious complication among patients with cancer, particularly in the setting of treatment-related immunosuppression.
- Trial name
- NCT06207487
- Testing
- Herpes Zoster episode
- Where
- Brazil
- Volunteers
- 150 people
- Sponsor
- AC Camargo Cancer Center
Neuralgia, Shingles
Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia
The purpose of this study is to gain initial safety and efficacy data on the experimental agent REN-1654 in patients with painful post-herpetic neuralgia (PHN).
- Conditions
- Neuralgia, Shingles, Peripheral Nervous System Disease
- Trial name
- NCT00099528
- Testing
- REN-1654
- Where
- 16 sites in United States
- Volunteers
- 90 people
- Sponsor
- Renovis
Postherpetic Neuralgia (PHN)
Pulsed Radiofrequency in Post Herptic Neuralgia
Comparing between regular pulsed Radiofrequency and irregular pulsed Radiofrequency for treatment of postherpetic neuralgia
- Trial name
- NCT07208032
- Testing
- Irregular Pulsed Radiofrequency (STP), regular pulsed Radiofrequency
- Where
- 2 sites in Egypt
- Volunteers
- 100 people
- Sponsor
- Sohag University
Herpes Zoster, Shingles
ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)
This study will describe the impact of vaccination with ZOSTAVAX™ on the epidemiology of herpes zoster (HZ) in a cohort of vaccinated participants 50 years or age or older, compared to a cohort of unvaccinated participants.
- Trial name
- NCT01600079
- Testing
- ZOSTAVAX™
- Volunteers
- 1,505,647 people, healthy volunteers welcome
- Sponsor
- Merck Sharp & Dohme LLC
Postherpetic; Neuralgia, Trigeminal (Etiology)
Esketamine Combined With PRF for Trigeminal Postherpetic Neuralgia
This trial's primary objective is to compare the analgesic efficacy of esketamine in combination with pulsed radiofrequency (PRF) against that of PRF monotherapy in patients with trigeminal postherpetic neuralgia (TPHN).
- Trial name
- NCT06914180
- Testing
- esketamine group, control group
- Where
- China
- Volunteers
- 174 people
- Sponsor
- Beijing Tiantan Hospital
Postherpetic Neuralgia
Single-dose to Evaluate the Pharmacokinetics of GTX-101 and Subcutaneous Injectable Bupivacaine in Healthy Subjects
This is a single-center, randomized, single-dose, active-controlled study in healthy male and female subjects. The study will enroll subjects to evaluate the PK of 3 dose strengths (50 mg, 100 mg and 200 mg) of GTX-101 compared…
- Trial name
- NCT05517486
- Testing
- GTX-101, Bupivacaine HCl subcutaneous injection
- Where
- Canada
- Volunteers
- 48 people, healthy volunteers welcome
- Sponsor
- Grace Therapeutics Inc.
Neuropathic Pain, Diabetic Peripheral Neuropathy (DPN)
Oral LAT8881 in Neuropathic Pain
This is a randomised, placebo-controlled, double-blind, crossover, phase IIa study to investigate the efficacy and safety of oral LAT8881 in neuropathic pain.
- Conditions
- Neuropathic Pain, Diabetic Peripheral Neuropathy (DPN), Post Herpetic Neuralgia (PHN)
- Trial name
- NCT03865953
- Testing
- LAT8881
- Where
- 6 sites in Australia, United Kingdom
- Volunteers
- 53 people
- Sponsor
- Lateral Pharma Pty Ltd
Neuropathic Pain From Spinal Cord Injury, Diabetic Peripheral Neuropathy
Validation Study of Neuropathic Pain
This study seeks to validate clinically evoked or obtained objective pain signs with the patient's corresponding quantified subjective pain symptoms.
- Conditions
- Neuropathic Pain From Spinal Cord Injury, Diabetic Peripheral Neuropathy, Post Herpetic Pain
- Trial name
- NCT00623961
- Where
- United States
- Volunteers
- 7 people
- Sponsor
- University of Wisconsin, Madison
Neuralgia, Postherpetic
Safety and Efficacy of Gabapentin in Postherpetic Neuralgia
Gabapentin and pregabalin are treatments for some types of neuropathic pain, including postherpetic neuralgia (PHN). However, these treatments usually need to be taken 3 times a day for effective pain control.
- Trial name
- NCT00335933
- Testing
- Gabapentin extended-release tablets
- Where
- United States
- Volunteers
- 378 people
- Sponsor
- Depomed
Proximal Humeral Fracture
LPHP-Philos-PHN Conservative Treatment
The aim of the study is to compare the results regarding fracture healing and functional outcome after the treatment of proximal humeral fractures with the four different treatment methods after 12w./6months and 12 months based…
- Trial name
- NCT00205959
- Testing
- Locking proximal humerus plate, Proximal Humerus Internal Locking System, Proximal Humerus Nail
- Where
- Germany
- Volunteers
- 640 people
- Sponsor
- AO Clinical Investigation and Publishing Documentation
Neuralgia, Postherpetic
Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)(0759-004)
The purpose of this study is to test the safety and effect of MK0759 in relieving neuropathic pain as experienced by patients with postherpetic neuralgia (PHN).
- Trial name
- NCT00245544
- Testing
- MK0759
- Volunteers
- 20 people
- Sponsor
- Merck Sharp & Dohme LLC
Chronic Pain, Neuropathic Pain
The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Sympathetic Ganglion Block
For patients scheduled to undergo upper limb sympathetic nerve block due to chronic neuropathic pain in the upper limb lasting more than 3 months, the ultrasound-guided stellate ganglion block group (S group) and the…
- Conditions
- Chronic Pain, Neuropathic Pain, Complex Regional Pain Syndromes, Post Herpetic Neuralgia
- Trial name
- NCT06130514
- Testing
- Ultrasound, Fluoroscopy
- Volunteers
- 118 people
- Sponsor
- Seoul National University
Postherpetic Neuralgia, Y-4
Y-4 to Treat the Postherpetic Neuralgia
The goal of this clinical trial is to assess the efficacy and safety of Y-4 in patients with postherpetic neuralgia(PHN). The main questions it aims to answer are: The efficacy and safety of Y-4 to treat PHN compared with…
- Conditions
- Postherpetic Neuralgia, Y-4, Pregabalin
- Trial name
- NCT07275762
- Testing
- Y-4 tables, Pregabalin
- Where
- China
- Volunteers
- 160 people
- Sponsor
- Neurodawn Pharmaceutical Co., Ltd.
Herpes Zoster, Postherpetic Neuralgia
Acupuncture in Herpes Zoster Neuralgia (ACUZoster)
Symptoms that herald herpes zoster include pruritus, dysesthesia and pain along the distribution of the involved dermatome. The most distressing symptom is typically pain and the most feared complication is postherpetic neuralgia…
- Conditions
- Herpes Zoster, Postherpetic Neuralgia, Pain
- Trial name
- ACUZoster (NCT00885586)
- Testing
- gabapentine, Acupuncture
- Where
- Germany
- Volunteers
- 68 people
- Sponsor
- Dominik Irnich